This program is intended for healthcare providers who are currently managing and treating patients with nonalcoholic steatohepatitis (NASH).
The series will focus on emerging treatment updates and review current NASH treatment guidelines.
Upon completion of this activity, participants should be able to:
Identify patients at increased risk for NASH
Incorporate into clinical practice the current standard of care for diagnosis, management and treatment of NAFLD/NASH
Describe recent evidence and recommendations regarding new and emerging diagnostic modalities for NASH
Describe the mechanisms of action of novel agents for the treatment of NASH
Discuss recent evidence regarding the safety and efficacy of new and emerging agents for the treatment of NASH
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and the Chronic Liver Disease Foundation. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.
The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest:
All individuals in control of the content of continuing education activities provided by the Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. All staff at the Annenberg Center for Health Sciences at Eisenhower and the Chronic Liver Disease Foundation have no relationships to disclose.
Learner Assurance Statement:
The Annenberg Center for Health Sciences at Eisenhower is committed to resolving all conflict of interest issues that could arise as a result of individuals who control activity content and who have relationships with ACCME-defined commercial interests. The Annenberg Center for Health Sciences at Eisenhower is committed to retaining only those individuals with financial interests that can be reconciled with the goals and educational integrity of the CME activity.
Americans with Disabilities Act:
The event staff will be glad to assist you with any special needs (i.e., physical, dietary). Please contact us prior to the event at 1-888-565-5321.
This program is supported by an educational grant from Intercept Pharmaceuticals.